PharmaLex Belgium

Zaventem ·KBO/BCE: BE 0667.829.063

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
30-09-2023	30-04-2024	23-07-2024	84 d late	2024-00290723
31-12-2022	31-07-2023	24-07-2023	7 d early	2023-00261280
31-12-2021	31-07-2022	29-07-2022	2 d early	2022-20241637
31-12-2020	31-07-2021	23-07-2021	8 d early	2021-40300251
31-12-2019	31-07-2020	23-07-2020	8 d early	2020-34000399
31-12-2018	31-07-2019	07-06-2019	54 d early	2019-16900135
31-12-2017	31-07-2018	06-07-2018	25 d early	2018-30100267

Metric	This company	Sector median	Position in the sector
Solvency	41.9%	41.2%	better than 51% of 826 sector peers
Net result	€578k	€28k	better than 89% of 827 sector peers
Equity	€2.46M	€160k	better than 81% of 828 sector peers
Staff costs	€3.97M	€159k	higher than 93% of 245 sector peers
Employees (FTE)	50.0	1.7	better than 95% of 260 sector peers

Line item	Code	2023
Balance sheet, Assets
TOTAL ASSETS	20/58	€5.87M
Fixed assets	21/28	€548k
Intangible fixed assets	21	€333k
Tangible fixed assets	22/27	€199k
Financial fixed assets	28	€15k
Current assets	29/58	€5.32M
Stocks & contracts in progress	3	€0
Amounts receivable within one year	40/41	€2.59M
Cash & bank	54/58	€1.92M
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€5.87M
Equity	10/15	€2.46M
Contributions / capital	10/11	€119k
Reserves	13	€121k
Accumulated profits (losses)	14	€2.22M
Provisions & deferred taxes	16	€76k
Amounts payable	17/49	€3.33M
Amounts payable after one year	17	€5k
Amounts payable within one year	42/48	€2.61M
Trade debts payable within one year	44	€941k
Income statement
Turnover	70	€6.99M
Operating result	9901	€832k
Financial income	75	€7k
Financial charges	65	€56k
Result before taxes	9903	€783k
Income taxes	67/77	€206k
Net result for the period	9904	€578k
Result to be appropriated	9905	€578k

Summary

Statutory auditor	IRE/IBR number	Tenure
Deloitte Réviseurs d'EntreprisesCurrent Statutory auditor · represented by Julie Delforge	-	26-04-2024 → present
AELVOET, SAMAN & PARTNERS Company auditor · represented by Wendy Saman succeeded by Deloitte Réviseurs d'Entreprises in 2024	A02061	01-01-2023 → 26-04-2024

NACE primary	Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies(70200)
Legal form	Public limited company(014)
Incorporation	19-12-2016
Status	Active
Postal code	1930